Follow the people · Insider
Annita Tanini
Annita Tanini files insider transactions with the SEC as a corp. controller & vp, finance of Keros Therapeutics (KROS). We hold 1 disclosed purchase or sale filed since 20 August 2026, 1 of them in the last 90 days.
- Files forKROS
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure20 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 August 2026 — 18 August 2026Corp. Controller & VP, Finance · Keros Therapeutics (KROS)1 Form 4 line · source: SEC Form 4
Everything they disclosed
1 entry, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,224 shares of Keros TherapeuticsSEC Form 420 August 2026Common Stock · traded 18 August 2026 · filed 20 August 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.